Drug Discovery Services Companies

Jan 2024Charles River Laboratories (US) Acquired SAMDI Tech, Inc., a company offering label-free HTS solutions for drug discovery research, expanding their technology portfolio.Collaborated with leading pharma companies to develop novel targeted therapies for unmet medical needs.

WuXi AppTec (China) Announced a strategic partnership with AstraZeneca to build a joint drug discovery center in China, focusing on innovative therapies for cancer and other diseases.Launched their "Open Access Drug Discovery Platform" providing researchers with access to diverse chemical libraries and drug discovery expertise.

Evotec (Germany) Formed a target and drug development collaboration with Boehringer Ingelheim focused on iPSC-based disease modeling for ophthalmologic illnesses.Expanded their global footprint with the opening of a new drug discovery and development center in South Korea.

Thermo Fisher Scientific (US) Launched their "Accelerate Bio" initiative, offering integrated drug discovery solutions and services to optimize the research and development process.Partnered with academic institutions to develop new technologies and tools for drug discovery research.

Sygnature Discovery (UK) Signed a multi-year contract with a major pharmaceutical company to provide drug discovery services for a pipeline of early-stage drug candidates.Announced the successful completion of an expansion project doubling their laboratory capacity to meet growing demand.

List of Drug Discovery Services Key Companies in the Market

• Advinus Therapeutics


• Abbott Laboratories Inc.


• Albany Molecular Research Inc. (AMRI)


• Agilent Technologies Ubiquigent


• Aurigene


• AstraZeneca PLC


• Charles River Laboratories International